We provide you with 20 years of free, institutional-grade data for DNLI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of DNLI. Explore the full financial landscape of DNLI stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$7,519,944
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Ho Carole | Sale | -3,743 | $13.58 | $50,830 | 2025-08-14 |
Schuth Alexander O. | Sale | -2,937 | $13.58 | $39,884 | 2025-08-14 |
Ho Carole | Derivatives Exercise | 44,655 | 2025-08-07 | ||
Watts Ryan J. | Sale | -495,282 | $15 | $7,429,230 | 2025-07-11 |
Watts Ryan J. | Derivatives Exercise | 495,282 | 2025-07-11 | ||
FLATLEY JAY T | Grant, award...etc | 6,037 | 2025-06-05 | ||
Klein Peter S | Grant, award...etc | 6,037 | 2025-06-05 | ||
Krognes Steve E. | Grant, award...etc | 6,037 | 2025-06-05 | ||
Schenkein David P | Grant, award...etc | 6,037 | 2025-06-05 | ||
Thornberry Nancy | Grant, award...etc | 6,037 | 2025-06-05 | ||
Tessier-Lavigne Marc | Grant, award...etc | 6,037 | 2025-06-05 | ||
BAKER BROS. ADVISORS LP | Grant, award...etc | 10,565 | 2025-06-05 | ||
BAKER BROS. ADVISORS LP | Grant, award...etc | 10,565 | 2025-06-05 | ||
Cook Jennifer E. | Grant, award...etc | 6,037 | 2025-06-05 | ||
Schuth Alexander O. | Sale | -15,162 | $20.22 | $306,576 | 2025-01-08 |
Watts Ryan J. | Sale | -36,916 | $20.22 | $746,442 | 2025-01-08 |
Krognes Steve E. | Sale | -3,339 | $20.81 | $69,485 | 2025-01-08 |
Ho Carole | Sale | -15,162 | $20.22 | $306,576 | 2025-01-08 |
Schuth Alexander O. | Grant, award...etc | 54,180 | 2025-01-07 | ||
Watts Ryan J. | Grant, award...etc | 54,180 | 2025-01-07 | ||
Ho Carole | Grant, award...etc | 54,180 | 2025-01-07 | ||
Krognes Steve E. | Sale | -30,000 | $20.25 | $607,500 | 2025-01-03 |
SATO VICKI L | Sale | -3,080 | $20.91 | $64,403 | 2025-01-03 |
Schuth Alexander O. | Derivatives Exercise | 6,708 | 2024-12-31 | ||
Ho Carole | Derivatives Exercise | 17,845 | 2024-11-27 | ||
Schuth Alexander O. | Derivatives Exercise | 20,516 | 2024-11-26 | ||
Schenkein David P | Sale | -59,441 | $32.09 | $1,907,462 | 2024-11-13 |
Schenkein David P | Derivatives Exercise | 47,165 | 2024-11-13 | ||
SATO VICKI L | Sale | -1,020 | $30 | $30,600 | 2024-11-12 |
Schuth Alexander O. | Sale | -15,558 | $29.68 | $461,761 | 2024-11-12 |
Schuth Alexander O. | Derivatives Exercise | 15,558 | 2024-11-12 | ||
SATO VICKI L | Sale | -3,080 | $27.07 | $83,376 | 2024-11-05 |
Watts Ryan J. | Sale | -40,000 | $27.69 | $1,107,600 | 2024-10-22 |
Watts Ryan J. | Derivatives Exercise | 40,000 | 2024-10-22 | ||
Krognes Steve E. | Sale | -30,000 | $29.03 | $870,900 | 2024-10-02 |
SATO VICKI L | Sale | -1,020 | $30 | $30,600 | 2024-09-16 |
SATO VICKI L | Sale | -3,080 | $24.99 | $76,969 | 2024-09-04 |
Schuth Alexander O. | Sale | -8,353 | $23.79 | $198,718 | 2024-08-22 |
Krognes Steve E. | Sale | -1,727 | $23.79 | $41,085 | 2024-08-22 |
Ho Carole | Sale | -22,458 | $23.79 | $534,276 | 2024-08-22 |
Watts Ryan J. | Sale | -2,260 | $23.79 | $53,765 | 2024-08-22 |
Ho Carole | Sale | -2,337 | $22.89 | $53,494 | 2024-08-15 |
Schuth Alexander O. | Sale | -2,272 | $22.89 | $52,006 | 2024-08-15 |
Krognes Steve E. | Sale | -30,688 | $21.79 | $668,692 | 2024-07-03 |
SATO VICKI L | Sale | -3,080 | $22.12 | $68,130 | 2024-07-03 |
Cook Jennifer E. | Sale | -1,458 | $21.73 | $31,682 | 2024-06-10 |
SATO VICKI L | Grant, award...etc | 5,967 | 2024-06-04 | ||
Cook Jennifer E. | Grant, award...etc | 5,967 | 2024-06-04 | ||
FLATLEY JAY T | Grant, award...etc | 5,967 | 2024-06-04 | ||
Schenkein David P | Grant, award...etc | 5,967 | 2024-06-04 | ||
Harris Erik | Grant, award...etc | 5,967 | 2024-06-04 | ||
Klein Peter S | Grant, award...etc | 5,967 | 2024-06-04 | ||
Krognes Steve E. | Grant, award...etc | 5,967 | 2024-06-04 | ||
Thornberry Nancy | Grant, award...etc | 5,967 | 2024-06-04 | ||
Tessier-Lavigne Marc | Grant, award...etc | 5,967 | 2024-06-04 | ||
SATO VICKI L | Sale | -1,674 | $20.39 | $34,133 | 2024-05-17 |
SATO VICKI L | Sale | -1,666 | $18.29 | $30,471 | 2024-04-17 |
Krognes Steve E. | Sale | -92,500 | $20.5 | $1,896,250 | 2024-04-02 |
SATO VICKI L | Sale | -1,666 | $20.1 | $33,487 | 2024-03-19 |
SATO VICKI L | Sale | -1,666 | $18.37 | $30,604 | 2024-02-20 |
Schuth Alexander O. | Sale | -22,844 | $17.29 | $394,973 | 2024-02-15 |
Watts Ryan J. | Sale | -9,589 | $17.29 | $165,794 | 2024-02-15 |
Krognes Steve E. | Sale | -2,750 | $17.29 | $47,548 | 2024-02-15 |
Ho Carole | Sale | -4,189 | $17.29 | $72,428 | 2024-02-15 |
Schuth Alexander O. | Derivatives Exercise | 50,000 | 2024-02-12 | ||
SATO VICKI L | Sale | -1,666 | $18.42 | $30,688 | 2024-01-18 |
Ho Carole | Sale | -4,668 | $19.02 | $88,785 | 2024-01-12 |
Watts Ryan J. | Sale | -7,818 | $19.78 | $154,640 | 2024-01-11 |
Schuth Alexander O. | Sale | -9,972 | $19.43 | $193,756 | 2024-01-09 |
Krognes Steve E. | Sale | -3,208 | $19.43 | $62,331 | 2024-01-09 |
Watts Ryan J. | Sale | -17,483 | $19.43 | $339,695 | 2024-01-09 |
Ho Carole | Sale | -9,972 | $19.43 | $193,756 | 2024-01-09 |
Schuth Alexander O. | Grant, award...etc | 53,720 | 2024-01-05 | ||
Ho Carole | Grant, award...etc | 53,720 | 2024-01-05 | ||
Watts Ryan J. | Grant, award...etc | 89,520 | 2024-01-05 | ||
SATO VICKI L | Sale | -1,666 | $23.39 | $38,968 | 2023-12-18 |
SATO VICKI L | Sale | -1,666 | $19.13 | $31,871 | 2023-11-16 |
SATO VICKI L | Sale | -1,666 | $20.66 | $34,420 | 2023-10-18 |
SATO VICKI L | Sale | -1,666 | $23.6 | $39,318 | 2023-09-19 |
Schuth Alexander O. | Sale | -2,522 | $23.17 | $58,435 | 2023-08-25 |
Ho Carole | Sale | -2,522 | $23.22 | $58,561 | 2023-08-25 |
Ho Carole | Sale | -2,478 | $22.6 | $56,003 | 2023-08-23 |
Schuth Alexander O. | Sale | -2,478 | $22.59 | $55,978 | 2023-08-23 |
Watts Ryan J. | Sale | -2,309 | $22.59 | $52,160 | 2023-08-23 |
Krognes Steve E. | Sale | -1,419 | $22.6 | $32,069 | 2023-08-23 |
SATO VICKI L | Sale | -1,666 | $24.3 | $40,484 | 2023-08-17 |
Ho Carole | Sale | -2,768 | $23.79 | $65,851 | 2023-08-16 |
The information provided in this report about DNLI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Denali Therapeutics Inc(NASDAQ:DNLI)

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. The company offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidates, including DNL201 that has completed Phase 1b clinical trials...
Website: http://www.denalitherapeutics.com
Founded: 2013
Full Time Employees: 281
Sector: Healthcare
Industry: Biotechnology